China Vaccine Frontrunner Says Shots Are Safe Amid Astra Setback
- Sinopharm vaccine has been given to hundreds of thousands
- AstraZeneca’s halted trial has no impact on Sinopharm testing
This article is for subscribers only.
China National Biotec Group Co. said none of the recipients of its two coronavirus shots has reported an obvious adverse reaction or infection, as the Chinese vaccine front-runner presses ahead with testing after AstraZeneca Plc suspended its trial.
Hundreds of thousands of people have received the Covid-19 shots so far, the vaccine developer, a subsidiary of state-owned drugmaker Sinopharm Group Co., said on its official WeChat account. The vaccine is being administered under an emergency-use program that allows experimental shots to be used for frontline workers before they complete final testing.